The Unique Characteristics of MET Exon 14 Mutation in Chinese Patients with NSCLC.

Si-Yang Liu,Lan-Ying Gou,An-Na Li,Na-Na Lou,Hong-Fei Gao,Jian Su,Jin-Ji Yang,Xu-Chao Zhang,Yang Shao,Zhong-Yi Dong,Qing Zhou,Wen-Zhao Zhong,Yi-Long Wu

Journal of Thoracic Oncology（2016）

引用 59|浏览36

暂无评分

摘要

MET exon 14 mutation per se may not be sufficiently robust for use in defining a subset of NSCLCs. Further research on MET exon 14 mutations, MET amplification, and MET overexpression is required. Maybe a panel of biomarkers will be necessary in the future.

查看译文

关键词

NSCLC,MET exon 14,Clinical characteristics,Chinese,Biomarker

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要